Multiple sclerosis (MS) is a chronic inflammatory, demyelinating, and neurodegenerative
disease of the central nervous system (CNS). In people with MS, impaired remyelination and …

Depression represents a prevalent and enduring mental disorder of significant concern
within the clinical domain. Extensive research indicates that depression is very complex …

A major therapeutic goal in demyelinating diseases, such as Multiple Sclerosis, is to improve
remyelination, thereby restoring effective axon conduction and preventing …

The visual system is one of the most accessible routes to study the central nervous system
under pathological conditions, such as in multiple sclerosis (MS). Non-invasive visual …

Cuprizone (CPZ) is a neurotoxic agent that is used to induce demyelination and
neurotoxicity in rats. This study aimed to investigate the protective potential of sulforaphane …

Huperzine A (HupA) is a natural acetylcholinesterase inhibitor (AChEI) with the advantages
of high efficiency, selectivity as well as reversibility and can exhibit significant therapeutic …

Background/Aims. Multiple sclerosis (MS) is an autoimmune disorder that affects the central
nervous system (CNS) primarily hallmarked by neuroinflammation and demyelination. The …

Demyelination is a frequent yet crippling neurological disease associated with multiple
sclerosis (MS). The cuprizone (CZ) model, which causes demyelination through oxidative …

Multiple sclerosis is a chronic inflammatory demyelinating disorder of the CNS characterized
by continuous myelin damage accompanied by deterioration in functions. Clobetasol …

Multiple sclerosis is an autoimmune disease characterised by demyelination in the central
nervous system. The cuprizone-induced demyelination model is often used in mice to test …